Home » Authors » Jennifer Boggs

Jennifer Boggs

Articles

ARTICLES

Koronis Working To Kill HIV By Increasing Viral Mutations

Oct. 14, 2005

By Jennifer Boggs

Koronis Working To Kill HIV By Increasing Viral Mutations

Oct. 14, 2005

By Jennifer Boggs

Raven's Series D: $48M For RAV12 Cancer Trials

Oct. 13, 2005

By Jennifer Boggs

Raven's Series D: $48M For RAV12 Cancer Trials

Oct. 13, 2005

By Jennifer Boggs

Praecis Continues Cost-Cutting Efforts, Sells Research Facility

Oct. 12, 2005

By Jennifer Boggs

CepTor Adding $20M To Test Myodur In Muscular Dystrophy

Oct. 12, 2005

By Jennifer Boggs

CepTor Adding $20M To Test Myodur In Muscular Dystrophy

Oct. 12, 2005

By Jennifer Boggs

Praecis Continues Cost-Cutting Efforts, Sells Research Facility

Oct. 12, 2005

By Jennifer Boggs

Vasogen Adds $40M Through Notes Sale For Celacade Work

Oct. 11, 2005

By Jennifer Boggs

Vasogen Adds $40M Through Notes Sale For Celacade Work

Oct. 11, 2005

By Jennifer Boggs

View All Articles by Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 4, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
ADPD 2025: Unlocking GLP-1's potential in neurodegeneration
BioWorld
At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...
Checkpoint inhibitor journey traces Chinese firms’ path to global revenue
BioWorld
Chinese pharmaceutical companies are making significant inroads into the global oncology market, particularly with the development and approval of immune...